
Markets on edge as tariff deadline looms & the future of vaccine development in the FDA 3/31/25
CNBC's "Fast Money"
00:00
Concerns Over CoreWeave's IPO Performance and Financial Viability
This chapter examines the steep decline in CoreWeave's stock price shortly after its IPO, driven by a negative report that raises alarms about its ties to NVIDIA and OpenAI. The analysis also weighs the company's pioneering role in AI infrastructure against troubling financial indicators like high debt and negative cash flow.
Transcript
Play full episode